Castle Biosciences CSTL Q1 2025 earnings
Reported May 5, 2025 · After market close
Revenue$88.0MBeat by $16.2M
EPS-$0.20Miss by $0.12
Revenue estimate$71.8M
EPS estimate-$0.08
Next report
Jul 30, 2026 (Today)Revenue estimate$86.2M
EPS estimate-$0.44
Financials
Q1 2025Valuation & ratios
Segments
Versus estimates
Revenue
Diluted EPS
Ask the moment Castle Biosciences reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Castle Biosciences report Q1 2025 earnings?
- Castle Biosciences (CSTL) reported Q1 2025 earnings on May 5, 2025 after market close.
- What were Castle Biosciences's Q1 2025 revenue and EPS?
- Castle Biosciences reported revenue of $88.0M and eps of $-0.20 for Q1 2025.
- Did Castle Biosciences beat estimates in Q1 2025?
- Revenue beat the consensus estimate of $71.8M by $16.2M. EPS missed the consensus estimate of $-0.08 by $0.12.
- How did Castle Biosciences's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 20.6% from $73.0M a year earlier and eps declined 122.2% from $-0.09.
- Where can I find Castle Biosciences's Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0001447362-25-000069) directly on SEC EDGAR. The filing index links above go to sec.gov.